Replies to post #64 on Citius Pharmaceuticals Inc (CTXR)

[ash111]

very risky to short on those numbers and upcoming catalyst. just sayin

pipeline includes two drugs with $500M opportunities that have already progressed through P2 studies. Mino-Lok is already in P3, $35M CASH!